Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.
Miesbach W, Meijer K, Coppens M, Kampmann P, Klamroth R, Schutgens R, Tangelder M, Castaman G, Schwäble J, Bonig H, Seifried E, Cattaneo F, Meyer C, Leebeek FWG. Miesbach W, et al. Among authors: coppens m. Blood. 2018 Mar 1;131(9):1022-1031. doi: 10.1182/blood-2017-09-804419. Epub 2017 Dec 15. Blood. 2018. PMID: 29246900 Free PMC article. Clinical Trial.
Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.
Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, Hamulyák K, Prins MH, Büller HR, van der Meer J. Lijfering WM, et al. Among authors: coppens m. Blood. 2009 May 21;113(21):5314-22. doi: 10.1182/blood-2008-10-184879. Epub 2009 Jan 12. Blood. 2009. PMID: 19139080 Free article.
von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease.
Sanders YV, Groeneveld D, Meijer K, Fijnvandraat K, Cnossen MH, van der Bom JG, Coppens M, de Meris J, Laros-van Gorkom BA, Mauser-Bunschoten EP, Leebeek FW, Eikenboom J; WiN study group. Sanders YV, et al. Among authors: coppens m. Blood. 2015 May 7;125(19):3006-13. doi: 10.1182/blood-2014-09-603241. Epub 2015 Feb 11. Blood. 2015. PMID: 25673639 Free article.
Clinical outcome of patients with a vitamin K antagonist-associated bleeding treated with prothrombin complex concentrate.
Brekelmans MPA, Abdoellakhan RA, Scheres LJJ, Biedermann JS, Hutten BA, Meijer K, Cate HT, Huisman MV, Kruip MJHA, Middeldorp S, Coppens M. Brekelmans MPA, et al. Among authors: coppens m. Res Pract Thromb Haemost. 2017 Nov 13;2(1):77-84. doi: 10.1002/rth2.12055. eCollection 2018 Jan. Res Pract Thromb Haemost. 2017. PMID: 30046709 Free PMC article.
Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
Schütte LM, Cnossen MH, van Hest RM, Driessens MHE, Fijnvandraat K, Polinder S, Beckers EAM, Coppens M, Eikenboom J, Laros-van Gorkom BAP, Meijer K, Nieuwenhuizen L, Mauser-Bunschoten EP, Leebeek FWG, Mathôt RAA, Kruip MJHA. Schütte LM, et al. Among authors: coppens m. BMJ Open. 2019 Apr 23;9(4):e022719. doi: 10.1136/bmjopen-2018-022719. BMJ Open. 2019. PMID: 31015264 Free PMC article.
BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease.
Atiq F, Fijnvandraat K, van Galen KPM, Laros-Van Gorkom BAP, Meijer K, de Meris J, Coppens M, Mauser-Bunschoten EP, Cnossen MH, van der Bom JG, Eikenboom J, Leebeek FWG; WiN study group. Atiq F, et al. Among authors: coppens m. Am J Hematol. 2019 Aug;94(8):E201-E205. doi: 10.1002/ajh.25499. Epub 2019 May 13. Am J Hematol. 2019. PMID: 31037771 Free PMC article. No abstract available.
One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P® /Humate P® treatment in von Willebrand disease patients.
de Jager NCB, Bukkems LH, Heijdra JM, Hazendonk CHCAM, Fijnvandraat K, Meijer K, Eikenboom J, Laros-van Gorkom BAP, Leebeek FWG, Cnossen MH, Mathôt RAA; OPTI-CLOT group. de Jager NCB, et al. J Thromb Haemost. 2020 Feb;18(2):295-305. doi: 10.1111/jth.14652. Epub 2019 Oct 21. J Thromb Haemost. 2020. PMID: 31557387 Free PMC article.
The limitation of genetic testing in diagnosing patients suspected for congenital platelet defects.
Blaauwgeers MW, van Asten I, Kruip MJHA, Beckers EAM, Coppens M, Eikenboom J, van Galen KPM, Huisman A, Korporaal SJA, Ploos van Amstel HK, Tamminga RYJ, Urbanus RT, Schutgens REG. Blaauwgeers MW, et al. Among authors: coppens m. Am J Hematol. 2020 Jan;95(1):E26-E28. doi: 10.1002/ajh.25667. Epub 2019 Nov 13. Am J Hematol. 2020. PMID: 31659778 Free PMC article. Review. No abstract available.
Patient Perspectives on Novel Treatments in Haemophilia: A Qualitative Study.
van Balen EC, Wesselo ML, Baker BL, Westerman MJ, Coppens M, Smit C, Driessens MHE, Leebeek FWG, van der Bom JG, Gouw SC. van Balen EC, et al. Among authors: coppens m. Patient. 2020 Apr;13(2):201-210. doi: 10.1007/s40271-019-00395-6. Patient. 2020. PMID: 31691206 Free PMC article.
Congenital platelet disorders and health status-related quality of life.
Blaauwgeers MW, Kruip MJHA, Beckers EAM, Coppens M, Eikenboom J, van Galen KPM, Tamminga RYJ, Urbanus RT, Schutgens REG; TiN study group. Blaauwgeers MW, et al. Among authors: coppens m. Res Pract Thromb Haemost. 2019 Dec 11;4(1):100-105. doi: 10.1002/rth2.12281. eCollection 2020 Jan. Res Pract Thromb Haemost. 2019. PMID: 31989090 Free PMC article.
306 results